Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer
Giacomo Oliveira, Ann Marie Egloff, Alexander B. Afeyan, et al.
Science Immunology (2023) Vol. 8, Iss. 87
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies
Housaiyin Li, Dan P. Zandberg, Aditi Kulkarni, et al.
Cancer Cell (2025)
Open Access | Times Cited: 2
T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1/IL-12 engineered probiotics
Jian‐Hong Liao, Hong Pan, Guojun Huang, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114086-114086
Open Access | Times Cited: 10
Resident memory T cells and cancer
Noah Veis Gavil, Katarina Cheng, David Masopust
Immunity (2024) Vol. 57, Iss. 8, pp. 1734-1751
Closed Access | Times Cited: 9
Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector Population
Anthony Z. Wang, Bryce L. Mashimo, Maximilian O. Schaettler, et al.
Cancer Discovery (2024) Vol. 14, Iss. 6, pp. 1106-1131
Closed Access | Times Cited: 8
Emerging roles of TBK1 in cancer immunobiology
Alex Miranda, Carl A. Shirley, Russell W. Jenkins
Trends in cancer (2024)
Closed Access | Times Cited: 8
The single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma
Zheyi Wang, Yue Zhao, Yang Wo, et al.
Cancer Letters (2024) Vol. 593, pp. 216951-216951
Closed Access | Times Cited: 8
The characterization of tumor immune microenvironment after neoadjuvant immunotherapy in head and neck squamous cell cancer using multiplex immunohistochemistry
Zhaohong An, Xiwei Zhang, Zhaoyang Wang, et al.
Oral Oncology (2025) Vol. 161, pp. 107151-107151
Closed Access | Times Cited: 1
Cancer ENO2 Induces Histone Lactylation-Mediated M2 Macrophage Polarization and Facilitates Metastasis of Head and Neck Squamous Cell Carcinoma
Chenran Wang, Lin Tan, Maohua Huang, et al.
Engineering (2025)
Open Access | Times Cited: 1
Targeting Dendritic Cell Dysfunction to Circumvent Anti-PD1 Resistance in Head and Neck Cancer
Shin Saito, Michihisa Kono, Hoang C.B. Nguyen, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 9, pp. 1934-1944
Open Access | Times Cited: 5
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma
Chang Gon Kim, Min Hee Hong, Dahee Kim, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 10, pp. 2097-2110
Closed Access | Times Cited: 4
Recurrent and Metastatic Head and Neck Cancer: Mechanisms of Treatment Failure, Treatment Paradigms, and New Horizons
William T. Barham, Marshall Patrick Stagg, Rula Mualla, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 144-144
Open Access
Immunosuppression and Outcomes in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck
Doriana Iancu, Ana Fulga, Doina Vesa, et al.
Clinics and Practice (2025) Vol. 15, Iss. 1, pp. 21-21
Open Access
Metformin as an immunomodulatory agent in enhancing head and neck squamous cell carcinoma therapies
Wenting Li, Naiming Liu, Mingwei Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189262-189262
Closed Access
The XCL1–XCR1 axis supports intestinal tissue residency and antitumor immunity
Amir Ferry, K Mempel, Alexander Monell, et al.
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 2
Closed Access
Coordinated immune networks in leukemia bone marrow microenvironments distinguish response to cellular therapy
Katie Maurer, Cameron Y. Park, Shouvik Mani, et al.
Science Immunology (2025) Vol. 10, Iss. 103
Closed Access
Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma
Julia Schiantarelli, Mouadh Benamar, Jihye Park, et al.
Cancer Cell (2025) Vol. 43, Iss. 2, pp. 308-316.e6
Open Access
A bibliometric and visualization analysis of the role of traditional Chinese medicine in cancer immunotherapy
Yixiao Lian, Jie Sun, Lin Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Tissue-resident memory T-cell expressions and their prognostic role in head and neck squamous cell carcinoma: a systematic review and meta-analysis
Anwar Ali, Muhammad Furqan Bari, Saba Arshad, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Current Progress and Future Directions of Immunotherapy in Head and Neck Squamous Cell Carcinoma
Edward S. Sim, Hoang C.B. Nguyen, Glenn J. Hanna, et al.
JAMA Otolaryngology–Head & Neck Surgery (2025)
Closed Access
Single-cell insights into HNSCC tumor heterogeneity and programmed cell death pathways
Yuanhao Chai, Jianlin Zhang, Wenwen Shao, et al.
Translational Oncology (2025) Vol. 54, pp. 102341-102341
Closed Access
Tissue‐Resident Memory CD8+ T Cells: Differentiation, Phenotypic Heterogeneity, Biological Function, Disease, and Therapy
Luming Xu, Lilin Ye, Qizhao Huang
MedComm (2025) Vol. 6, Iss. 3
Open Access
Neoadjuvant immune checkpoint therapy: Enabling insights into fundamental human immunology and clinical benefit
Kristen E. Pauken, Omar Alhalabi, Sangeeta Goswami, et al.
Cancer Cell (2025)
Closed Access
Constructing a Predictive Model for PD-1 Blockade Therapy in Pan-Cancer Based on Machine Learning
Hening Li, S. Li, Liang Xiong, et al.
Research Square (Research Square) (2025)
Closed Access
Single-cell meta-analysis of T cells reveals clonal dynamics of response to checkpoint immunotherapy
Ofir Shorer, Asaf Pinhasi, Keren Yizhak
Cell Genomics (2025), pp. 100842-100842
Open Access
Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma
Kevin J. Contrera, Sagar Kansara, Neerav Goyal, et al.
JAMA Otolaryngology–Head & Neck Surgery (2025)
Closed Access
Page 1 - Next Page

Scroll to top